Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Boelens, Jaap Jan  [Clear All Filters]
2021
Mlakar SJurkovic, Uppugunduri SChakradhar, Nava T, Mlakar V, Golay H, Robin S, Waespe N, Rezgui MAziz, Chalandon Y, Boelens JJan, et al. Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2021.
Beerepoot S, Heijst H, Roos B, Wamelink MMC, Boelens JJan, Lindemans CA, van Hasselt PM, Jacobs EH, Van der Knaap MS, Teunissen CE, et al. Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy. Brain. 2021.
Orfali N, Zhang M-J, Allbee-Johnson M, Boelens JJan, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, et al. Planned granulocyte-colony stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with Thymoglobulin for myeloid malignancy. Transplant Cell Ther. 2021.
A Nijstad L, Nierkens S, Lindemans CA, Boelens JJan, Bierings M, A Versluys B, van der Elst KCM, Huitema ADR. Population pharmacokinetics of clofarabine for allogeneic hematopoietic cell transplantation in pediatric patients. Br J Clin Pharmacol. 2021.
Chiesa R, Boelens JJan, Duncan CN, Kuehl J-S, Sevin C, Kapoor N, Prasad VK, Lindemans CA, Jones SA, Amartino HM, et al. Variables Affecting Outcomes After Allogeneic Hematopoietic Stem Cell Transplant for Cerebral Adrenoleukodystrophy. Blood Adv. 2021.